<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04730063</url>
  </required_header>
  <id_info>
    <org_study_id>1685958-2</org_study_id>
    <nct_id>NCT04730063</nct_id>
  </id_info>
  <brief_title>Evaluation of Novel Cardio-Pulmonary Physiological Monitor, the VQm PHM™, for Acute Care Medicine</brief_title>
  <official_title>Prospective Non-Interventional Study Evaluating Non-invasive Measurements of Pulmonary Blood Flow, Functional Residual Capacity, Shunt Fraction Index and Airway Dead Space Measured With the VQm PHM™ to Clinical Gold Standards</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rostrum Medical Innovations Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rostrum Medical Innovations Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, observational study to assess agreement of pulmonary health parameters&#xD;
      measured by a new non-invasive physiologic monitor, the VQm pulmonary health monitor (PHM)™&#xD;
      with clinical gold standards.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The specific aim of this study is to evaluate the intermittent non-invasive measurements of&#xD;
      pulmonary function: pulmonary blood flow (PBF), functional residual capacity (FRC), shunt&#xD;
      fraction index (Qsi) and airway dead space measured by the VQm PHM™ compared to known&#xD;
      clinical standards. PBF will be compared to continuous and intermittent bolus thermodilution&#xD;
      cardiac output as measured through a Swan-Ganz catheter. FRC will be compared to an FRC&#xD;
      measurement provided by a standard nitrogen washout method. Qsi will be compared to shunt&#xD;
      fraction calculated through mixed venous and arterial blood gas values (VBGs/ABGs). Airway&#xD;
      dead space will be compared to an airway dead space measurement provided by a ventilator.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 17, 2021</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of pulmonary function parameters to known clinical standards</measure>
    <time_frame>Through study completion, an average of 12 months</time_frame>
    <description>Assess agreement between measurements from VQm PHM™ to clinical gold standards</description>
  </primary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Elective Procedures Requiring Mechanical Ventilation</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VQm PHM™</intervention_name>
    <description>Procedure: Non-invasive measurements obtained with the VQm PHM™</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled for elective surgery requiring mechanical ventilation&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age greater than 18 years&#xD;
&#xD;
          -  Scheduled for an elective surgical procedure with an anticipated duration of more than&#xD;
             2 hours requiring general anesthesia without the use of inhalation anesthetics&#xD;
&#xD;
          -  Surgical procedure that requires pressure-controlled positive pressure ventilation&#xD;
             using an endotracheal tube&#xD;
&#xD;
          -  Surgical procedure that requires the use of intra-arterial pressure monitoring and/or&#xD;
             a Swan-Ganz catheter for the monitoring of continuous cardiac output&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who require ventilation tidal volumes less than 250cc&#xD;
&#xD;
          -  Age less than 18 years&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Prisoners&#xD;
&#xD;
          -  Surgical procedure which requires carbon dioxide (CO2) insufflation&#xD;
&#xD;
          -  Unable to tolerate a transient increase in inhaled CO2&#xD;
&#xD;
          -  Unable to tolerate a transient increase in inhaled nitrous oxide (N2O) or use of N2O&#xD;
             is contraindicated&#xD;
&#xD;
          -  Patients who require a high fraction of inspired oxygen (FiO2) (&gt;70%) to maintain a&#xD;
             hemoglobin saturation (SpO2&gt;98%)&#xD;
&#xD;
        Women, minorities or non-English speaking subjects will not be excluded&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neal W Fleming, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Director, Cardiovascular and Thoracic Anesthesiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Neal W Fleming, M.D., Ph.D.</last_name>
    <phone>916-734-5394</phone>
    <email>nwfleming@ucdavis.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nathan Ayoubi, BSc</last_name>
    <phone>604 562 6198</phone>
    <email>nathan@rostrummedical.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UC Davis Medical Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neal W Fleming, M.D., Ph.D.</last_name>
      <phone>916-734-5394</phone>
      <email>nwfleming@ucdavis.edu</email>
    </contact>
    <investigator>
      <last_name>Neal W Fleming, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>January 25, 2021</study_first_submitted>
  <study_first_submitted_qc>January 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2021</study_first_posted>
  <last_update_submitted>August 10, 2021</last_update_submitted>
  <last_update_submitted_qc>August 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Physiologic Monitors</keyword>
  <keyword>Acute Care Medicine</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

